MPM BioVentures 2014 (B), L.P., Insider at Werewolf Therapeutics, Inc. (HOWL), sold 342,239 shares at $0.97 ($317K) on 2025-12-04, disclosed to the SEC on 2025-12-04.
Scheduled sale ($317k) by Insider under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.89 | 59,277 | $53K | 16.7% |
| 2 | $0.89 | 59,277 | $53K | 16.7% |
| 3 | $0.87 | 57,225 | $50K | 15.7% |
| 4 | $0.97 | 83,230 | $81K | 25.5% |
| 5 | $0.97 | 83,230 | $81K | 25.5% |
| Total | $0.93 avg | 342,239 |
| $317K |
| 100% |